Cost-effectiveness Analysis of Toripalimab Plus Chemotherapy Versus Chemotherapy Alone for Advanced Non-Small Cell Lung Cancer in China
Frontiers in Immunology（2023）
关键词
toripalimab,PD-1,cost-effectiveness,partitioned survival model,advanced non-small cell lung cancer (advanced NSCLC),chemothearpy,China
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要